Categories: Technology

Mandatory disclosure of holding and notice of trade in IDEX Biometrics 23 July 2025

 | Source: IDEX BIOMETRICS ASA

Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider.

Tranche 1 of the private placement amounted to 4,731,594 shares. As disclosed separately, Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, participated in the private placement and subscribed for 739,360 shares in Tranche 1.

In connection with the private placement, the manager of the private placement, IDEX Biometrics and Mr. Storbråten entered into a share lending agreement.

Mr. Storbråten has lent 4,731,594 shares, ISIN NO0013536078, in connection with the settlement of Tranche 1. The shares have been lent, not sold, and will be returned in due course. 

After the subscription by Pinchcliffe and the temporary lending of shares, Mr. Storbråten and close relations hold 6,503,476 or 12,48% shares of the total outstanding shares and votes in IDEX Biometrics after completion of Tranche 1.

Contact person
Anders Storbråten, CEO and CFO
Tel: +47 4163 8582
E-mail: ir@idexbiometrics.com

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

About this notice
This notice was issued by Erling Svela, Vice president of finance, on 23 July 2025 at 11:50 CET on behalf of IDEX Biometrics ASA. The information about the lending shall be disclosed according to article 19 no. 3 of the EU Market Abuse Regulation (EU 596/2014). The information about shareholding shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA). The information is published in accordance with section 5‑12 of the Norwegian Securities Trading Act.

GlobeNews Wire

Recent Posts

MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe…

8 hours ago

Boston Dental Named The Best Dentist in Boston

Prestigious Recognition Highlights Boston Dental's Commitment to Excellence in Dental and Aesthetic Services June 19,…

8 hours ago

Comprehensive Healthcare opens Columbia Valley Center for Recovery, the Tri-Cities’ first inpatient behavioral health treatment and recovery facility

YAKIMA, Wash., June 19, 2026 (GLOBE NEWSWIRE) -- Comprehensive Healthcare today announced that the Columbia…

8 hours ago

TheDoseReport Announces Which GLP-1 is Best? Semaglutide and Tirzepatide

NEW YORK, June 21, 2026 (GLOBE NEWSWIRE) -- TheDoseReport.com Releases Analysis: Which GLP-1 is Best?…

16 hours ago

From Living Rooms to Garages: GARVEE Expands Affordable Cooling Solutions for Summer 2026

ONTARIO, Calif., June 21, 2026 (GLOBE NEWSWIRE) -- GARVEE launches the 2026 Summer AC Campaign…

16 hours ago

Crypto News: AlphaPepe Expands Listings With BiFinance CEX Deal as Bitcoin Price Prediction Eyes $250,000

MONACO, June 20, 2026 (GLOBE NEWSWIRE) -- Crypto news is turning toward AlphaPepe after the…

16 hours ago